Delving into the Latest Updates on NeuDirection Limited with Synapse

Overview

Tags

Nervous System Diseases

Other Diseases

Eye Diseases

Chemical drugs

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	3

Top 5 Drug Type	Count

Chemical drugs	2
Small molecule drug	1

Top 5 Target	Count

GPCR(G-protein coupled receptor)	3

评估健康成人受试者单次皮下注射（SC）Neu-001的安全性和耐受性。次要目的：评估健康成人受试者单次皮下注射（SC）Neu-001的药代动力学（PK）特征。探索性目的：评估健康成人受试者单次皮下注射（SC）Neu-001后对长时记忆的影响。

[Translation]

To evaluate the safety and tolerability of a single subcutaneous (SC) injection of Neu-001 in healthy adult subjects. Secondary objective: To evaluate the pharmacokinetic (PK) characteristics of Neu-001 in healthy adult subjects after a single subcutaneous (SC) injection. Exploratory objective: To evaluate the effects of a single subcutaneous (SC) injection of Neu-001 on long-term memory in healthy adult subjects.

Start Date-

Sponsor / Collaborator

NeuDirection Limited

100 Clinical Results associated with NeuDirection Limited

Login to view more data

0 Patents (Medical) associated with NeuDirection Limited

Login to view more data

100 Deals associated with NeuDirection Limited

Login to view more data

100 Translational Medicine associated with NeuDirection Limited

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 01 Sep 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

2

1

Phase 1

Login to view more data